Search Results 171-180 of 22999 for colitis
This is a Phase 2, multicenter, proof-of-concept platform study in adult participants with moderately to severely active ulcerative colitis (UC). The primary ...
Confirmed diagnosis of ulcerative colitis (UC) and a history of total abdominal colectomy (TAC) with ileal pouch anal anastomosis (IPAA); Closure of ...
For treatment of ulcerative colitis: For oral dosage form (enteric-coated tablets):. Adults—At first, 500 to 1000 milligrams (mg) every 6 to 8 ...
Infliximab-qbtx injection is used to reduce the symptoms of moderate-to-severely active Crohn's disease and ulcerative colitis in adults and children who have ...
Proctitis caused by inflammatory bowel disease. Treatment of proctitis related to ulcerative colitis or Crohn's disease focuses on reducing inflammation in the ...
The purpose of this study is to assess the effectiveness and safety of BMS-986165 in ulcerative colitis. Participation eligibility. Participant eligibility ...
About this study. The purpose of this study is to determine the impact of HBOT (hyperbaric oxygen therapy) on clinical response/remission to medical therapy ...
Budesonide is a steroid (cortisone-like) medicine. Budesonide extended-release tablets are used to help get active mild to moderate ulcerative colitis under ...
Colon ischemia, also called ischemic colitis, affects the large intestine. Other types of ischemia affect the small intestine. These are acute mesenteric ...
Complex Crohn's Disease and Ulcerative Colitis · Checkpoint-inhibitor colitis / enterocolitis · Mucosal Immunology · Personalized Medicine in IBD ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your gift doubles in impact to help more patients.